JAMES BRADY, M.D.
Medical Practice at County Road 39A, South Hampton, NY
License number
New York 201779
Category
Medical Practice
Type
Plastic Surgery
License number
New York 201779
Category
Medical Practice
Type
Surgery of the Hand
Address
Address
686 County Road 39A BUILDING 2, South Hampton, NY 11968
Phone
(631) 287-0711
(631) 287-1080 (Fax)
(631) 287-1080 (Fax)
Organization information
See more information about JAMES BRADY at bizstanding.comJames Brady
South Hampton, NY
Industry:
Medical Doctor's Office, Nonclassifiable Establishments, Whol Hardware
Addresses:
325 Meeting House Ln, South Hampton, NY 11968
PO Box 6070, South Hampton, NY 11969
PO Box 6070, South Hampton, NY 11969
Medical Doctors:
James Brady (Medical Doctor, President, Principal),Elisa M. Santos (Medical Doctor)
JOSEPH L. DE BELLIS, M.D., JAMES A. BRADY, M.D., PC
86 Sanford Pl, Southampton, NY 11968
Status:
Inactive
Inactive reason:
Dissolution
Registration:
Feb 25, 2003
Inactive since:
May 16, 2005
State ID:
2874061
Business type:
DOMESTIC PROFESSIONAL CORPORATION
Professional information
James Andrew Brady, Southampton NY
Specialties:
Plastic Surgeon
Address:
325 Meeting House Ln, Southampton, NY 11968
686 County Road 39A, Southampton, NY 11968
686 County Road 39A, Southampton, NY 11968
Biocompatible Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In The Blood
US Patent:
2006005, Mar 16, 2006
Filed:
Oct 19, 2005
Appl. No.:
11/255132
Inventors:
James Brady - South Hampton NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
International Classification:
A61K 39/00
US Classification:
424140100
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In Physiologic Fluids
US Patent:
2002019, Dec 26, 2002
Filed:
Dec 21, 2001
Appl. No.:
10/036745
Inventors:
James Brady - South Hampton NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
Assignee:
Renal Tech International
International Classification:
A61M001/00
US Classification:
604/027000
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluid by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In The Blood
US Patent:
8349550, Jan 8, 2013
Filed:
Dec 2, 2010
Appl. No.:
12/928058
Inventors:
James A Brady - South Hampton NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsvurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Jamie A Salsberg - New York NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsvurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Jamie A Salsberg - New York NY, US
Assignee:
Cytosorbents, Inc. - Monmouth Junction NJ
International Classification:
A01N 1/00, A01N 1/02
US Classification:
435 11, 435 12, 4352841
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In Physiologic Fluids
US Patent:
2005006, Mar 24, 2005
Filed:
Nov 4, 2004
Appl. No.:
10/981055
Inventors:
James Brady - South Hampton NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
International Classification:
C02F001/44
US Classification:
210645000
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in physiologic fluid by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In Blood Products
US Patent:
2005023, Oct 27, 2005
Filed:
Apr 13, 2005
Appl. No.:
11/105140
Inventors:
James Brady - South Hampton NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
International Classification:
A01N001/02
US Classification:
435002000
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Selective Adsorption Devices And Systems
US Patent:
2002019, Dec 26, 2002
Filed:
Dec 21, 2001
Appl. No.:
10/038053
Inventors:
James Brady - South Hampton NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
James Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank Norris - New York NY, US
Peter Quartararo - New York NY, US
Jamie Salsberg - New York NY, US
Assignee:
Renal Tech International
International Classification:
A61K039/395, A61M037/00
US Classification:
424/140100, 604/005040
Abstract:
Intravenous, or indwelling, or integrated multi-functional devices and systems reduce levels of a targeted compound in blood by selective adsorption. The devices and systems can be used, e.g., to reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices and systems are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices and systems serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Biocompatible Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In The Blood
US Patent:
7556768, Jul 7, 2009
Filed:
Apr 4, 2007
Appl. No.:
11/732687
Inventors:
James A Brady - South Hampton NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyuruoa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Jamie A Salsberg - New York NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyuruoa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Jamie A Salsberg - New York NY, US
Assignee:
MedaSorb Corporation - Monmouth Junction NJ
International Classification:
A61M 1/00
US Classification:
422 44
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Devices, Systems, And Methods For Reducing Levels Of Pro-Inflammatory Or Anti-Inflammatory Stimulators Or Mediators In Blood Products
US Patent:
8334094, Dec 18, 2012
Filed:
May 20, 2010
Appl. No.:
12/800683
Inventors:
James A Brady - South Hampton NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Peter Quartararo, Jr. - New York NY, US
Jamie A Salsberg - New York NY, US
James F Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyurupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M Norris - New York NY, US
Peter Quartararo, Jr. - New York NY, US
Jamie A Salsberg - New York NY, US
Assignee:
Cytosorbents, Inc. - Monmouth Junction NJ
International Classification:
A01N 1/00, B01J 20/00, B01J 20/26, A61M 37/00
US Classification:
435 2, 502400, 502402, 604 401, 604 501, 604 601
Abstract:
Devices, systems, and methods reduce levels of pro-inflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of pro-inflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among pro-inflammatory or anti-inflammatory stimulators or mediators.
Biocompatible Devices, Systems, And Methods For Reducing Levels Of Proinflammatory Or Antiinflammatory Stimulators Or Mediators In The Blood
US Patent:
2010006, Mar 18, 2010
Filed:
Jul 6, 2009
Appl. No.:
12/459680
Inventors:
James A. Brady - South Hampton NY, US
James F. Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyunupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M. Norris - New York NY, US
Jamie A. Salsberg - New York NY, US
James F. Winchester - New York NY, US
Vadim Davankov - Moscow, RU
Maria Tsyunupa - Moscow, RU
Ludmila Pavlova - Moscow, RU
Frank M. Norris - New York NY, US
Jamie A. Salsberg - New York NY, US
International Classification:
A61M 1/38
US Classification:
604 504
Abstract:
Devices, systems, and methods reduce levels of proinflammatory or anti-inflammatory stimulators or mediators in blood by selective adsorption. The devices, systems, and methods are useful in situations where abnormal levels of or unregulated or excessive interaction among proinflammatory or anti-inflammatory stimulators or mediators occur, or during events that do induce or have the potential for inducing abnormal production of proinflammatory or anti-inflammatory stimulators or mediators. The devices, systems, and methods serve to prevent, control, reduce, or alleviate the severity of the inflammatory response and disease states that are associated with abnormal levels of or unregulated or excessive interaction among proinflammatory or anti-inflammatory stimulators or mediators.